Seven female red Duroc pigs (16-20 kg) were used to create 6 to 8 deep partial-thickness dorsal wounds each of about 25 cm 2 per animal. With multiple dermatome passes, each wound depth was uniformly excised to be 0.070 in. to create near full-thickness excision in the center and deep partial-thickness in the periphery as previously described in the literature. Animals received either standard bandage dressings, blank hydrogel alone (placebo), or FAKI-releasing hydrogel dressings immediately after wounding. Dressings and hydrogels were changed every 2 days until the wounds closed and then every 4 days thereafter. Wound closure rate, HTS formation, and regrowth of hair follicles and skin appendages were evaluated over 6 months.
RESULTS:
Excisional wound healing was significantly accelerated with localized FAKI hydrogel treatment. FAKItreated wounds closed significantly faster on day 14 ± 2.3 vs. day 24 ± 1.6 for control wounds vs. 24 ± 0.8 for placebo wounds (N=8 for each group, statistical difference at p<0.01). Visually inspected scars were dramatically reduced with FAKI hydrogel treatment compared to untreated control or placebo wounds. Lower Visual Analog Scale (VAS) scores relative to untreated control wounds determined by a panel of blinded scar experts indicated improved scar appearance evaluated at Day 90 and at Day 180 (control VAS=100 vs. placebo 93 ± 4.6 vs. FAKI 58 ± 6.5, N=8 for each group, statistical difference at p<0.001). FAKI-treated wounds regenerated skin appendages including hair follicles and eccrine glands. Histology and immunoblotting analyses demonstrated that α-smooth muscle actin expression in the scar lesions was substantially attenuated with FAKI treatment suggesting that FAKI blocks myofibroblast recruitment and activation. Lastly, the collagen fibril architecture of FAKI-treated wound was very similar to the basket weave pattern of unwounded pig skin while collagen organization of untreated control and placebo wounds appeared randomly disorganized.
CONCLUSION:
Biomaterial-based topical delivery of FAKI was effective in improving wound healing, reducing scar formation, and promoting regeneration in a large animal model, and holds great potential as an effective therapeutic strategy for wound and scar management of large and deep dermal wounds. RESULTS: 109 patients met inclusion criteria. Preoperatively, 95% of patients described taking prescription medication for their MH pain. Type of medication varied among patients but included abortive in 46%, preventative in 54%, rescue in 62%, and antiemetic in 18%. At twelve months postoperatively, 64% of patients reported using less prescription medication. Patients reported a 67% decrease in the number of days they took medication. Twenty percent stopped medications altogether. Fifty-two percent of patients reported that their migraine medication helped them more compared to preoperatively.
MH surgery has been shown to improve symptoms in up to 90% of patients. We now show that it is also associated with a significant decrease in medication use. It is important for surgeons to be aware of this data as we continue to counsel future patients.
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